Earth Science Tech Reports Fiscal 2026 Growth as It Integrates Telemedicine, Pharmacy, and Fulfillment Platform

Earth Science Tech Inc. announced fiscal year 2026 results with revenue up 8% to $35.7 million, highlighting the company's progress in building a fully integrated healthcare platform connecting telemedicine, pharmacy, and fulfillment.

DC Metrowire Staff
Healthcare
Earth Science Tech Reports Fiscal 2026 Growth as It Integrates Telemedicine, Pharmacy, and Fulfillment Platform

Earth Science Tech Inc. (OTC: ETST) reported its fiscal year 2026 financial results for the year ended March 31, 2026, demonstrating growth across key metrics as the company advances its strategy of operating a diversified holdings model spanning healthcare, pharmaceuticals, telemedicine, real estate, and consumer businesses. Revenue increased 8% to $35.7 million, gross profit rose 5% to $25.5 million, net income grew 11% to $3.6 million, and total assets increased 27% to $9 million.

CEO Giorgio R. Saumat attributed the results to ETST’s efforts to fully integrate the patient experience from telemedicine to pharmacy to fulfillment. The company’s core value proposition centers on the seamless integration of patient care, achieved through the synergy of its specialized subsidiaries. Earth Science Tech operates as a diversified holding company focused on the health and wellness sector, with a principal operating strategy of building a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment.

The company’s healthcare operations are supported by investments in real estate and asset management activities, as well as a consumer products business. This integrated model aims to streamline the patient journey, reducing friction between consultation, prescription, and delivery. For more details on the full article, visit https://nnw.fm/u6mhk.

The results underscore the potential of ETST’s approach in a healthcare landscape increasingly focused on digital transformation and patient-centric care. By linking telemedicine services directly with pharmacy operations and fulfillment, the company may be positioned to capture greater efficiency and patient loyalty. The 27% growth in total assets to $9 million suggests ongoing investment in infrastructure and capabilities to support this integration.

Earth Science Tech’s diversified holdings model also provides a buffer against volatility in any single sector, as the company balances healthcare operations with real estate and consumer businesses. This structure may appeal to investors seeking exposure to multiple growth areas through a single entity. The company’s latest news and updates are available in its newsroom at https://nnw.fm/ETST.

As the healthcare industry continues to embrace telemedicine and integrated care models, Earth Science Tech’s progress in combining these elements with pharmacy and fulfillment could serve as a case study for other companies looking to consolidate the patient experience. The fiscal 2026 results provide a snapshot of a company executing on its vision, with financial metrics indicating steady growth and operational focus. Investors and industry observers will likely watch how ETST scales this integrated platform in the coming fiscal year.

Blockchain Registration

QR Code for Blockchain Registration